Recent progress in the pathophysiology of fibrinogen

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A great deal of evidence suggests that fibrinogen is implicated in many vascular disorders resulting from atherothrombosis. However, it has not yet been possible either to establish with certainty whether elevated plasma fibrinogen levels cause, or arise as a consequence of, vascular pathology; or to include fibrinogen in the battery of laboratory tests widely used to predict the risk of thrombosis. This article provides an overview of the progress that has taken place in recent years in our understanding of the pathogenetic role of high plasma fibrinogen levels; the identification of genetic markers of atherothrombotic disease; and the clarification of the complex epidemiology of plasma fibrinogen levels as it relates to genotype and environment. The recent improvement in methodology used to measure plasma fibrinogen levels (which should lend to the wider use of fibrinogen assays in clinical practice) is also reviewed.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalEuropean Heart Journal
Volume16
Issue numberSUPPL. A
Publication statusPublished - 1995

Fingerprint

Fibrinogen
Blood Vessels
Genetic Markers
Epidemiology
Thrombosis
Genotype
Pathology

Keywords

  • Atherosclerosis
  • Atherothrombosis
  • Chronic infection
  • Epidemiology
  • Fibrinogen assays
  • Fibrinogen standard
  • Genotype
  • Lifestyle modification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Recent progress in the pathophysiology of fibrinogen. / Mannucci, P. M.

In: European Heart Journal, Vol. 16, No. SUPPL. A, 1995, p. 25-30.

Research output: Contribution to journalArticle

@article{58ba6b436283470daedacc07006b8af7,
title = "Recent progress in the pathophysiology of fibrinogen",
abstract = "A great deal of evidence suggests that fibrinogen is implicated in many vascular disorders resulting from atherothrombosis. However, it has not yet been possible either to establish with certainty whether elevated plasma fibrinogen levels cause, or arise as a consequence of, vascular pathology; or to include fibrinogen in the battery of laboratory tests widely used to predict the risk of thrombosis. This article provides an overview of the progress that has taken place in recent years in our understanding of the pathogenetic role of high plasma fibrinogen levels; the identification of genetic markers of atherothrombotic disease; and the clarification of the complex epidemiology of plasma fibrinogen levels as it relates to genotype and environment. The recent improvement in methodology used to measure plasma fibrinogen levels (which should lend to the wider use of fibrinogen assays in clinical practice) is also reviewed.",
keywords = "Atherosclerosis, Atherothrombosis, Chronic infection, Epidemiology, Fibrinogen assays, Fibrinogen standard, Genotype, Lifestyle modification",
author = "Mannucci, {P. M.}",
year = "1995",
language = "English",
volume = "16",
pages = "25--30",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "SUPPL. A",

}

TY - JOUR

T1 - Recent progress in the pathophysiology of fibrinogen

AU - Mannucci, P. M.

PY - 1995

Y1 - 1995

N2 - A great deal of evidence suggests that fibrinogen is implicated in many vascular disorders resulting from atherothrombosis. However, it has not yet been possible either to establish with certainty whether elevated plasma fibrinogen levels cause, or arise as a consequence of, vascular pathology; or to include fibrinogen in the battery of laboratory tests widely used to predict the risk of thrombosis. This article provides an overview of the progress that has taken place in recent years in our understanding of the pathogenetic role of high plasma fibrinogen levels; the identification of genetic markers of atherothrombotic disease; and the clarification of the complex epidemiology of plasma fibrinogen levels as it relates to genotype and environment. The recent improvement in methodology used to measure plasma fibrinogen levels (which should lend to the wider use of fibrinogen assays in clinical practice) is also reviewed.

AB - A great deal of evidence suggests that fibrinogen is implicated in many vascular disorders resulting from atherothrombosis. However, it has not yet been possible either to establish with certainty whether elevated plasma fibrinogen levels cause, or arise as a consequence of, vascular pathology; or to include fibrinogen in the battery of laboratory tests widely used to predict the risk of thrombosis. This article provides an overview of the progress that has taken place in recent years in our understanding of the pathogenetic role of high plasma fibrinogen levels; the identification of genetic markers of atherothrombotic disease; and the clarification of the complex epidemiology of plasma fibrinogen levels as it relates to genotype and environment. The recent improvement in methodology used to measure plasma fibrinogen levels (which should lend to the wider use of fibrinogen assays in clinical practice) is also reviewed.

KW - Atherosclerosis

KW - Atherothrombosis

KW - Chronic infection

KW - Epidemiology

KW - Fibrinogen assays

KW - Fibrinogen standard

KW - Genotype

KW - Lifestyle modification

UR - http://www.scopus.com/inward/record.url?scp=0028937278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028937278&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 25

EP - 30

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - SUPPL. A

ER -